Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University Hospital, Geneva Swiss National Science Foundation |
---|---|
Information provided by: | University Hospital, Geneva |
ClinicalTrials.gov Identifier: | NCT00221520 |
High-risk critically ill patients often require mechanical ventilation either to primarily support the respiratory function or when the ventilation is insufficient to maintain adequate gas exchanges as a result of other organ impairment. In order to tolerate this aggressive mechanical support, enhance patient synchrony with the ventilator, and relieve pain and anxiety, analgesia and sedation are provided. It is suggested that an inappropriate use of sedation and analgesia may prolong the duration of mechanical ventilation and increase the risk of specific adverse outcomes such as ventilator associated pneumonia. Despite the widespread use of sedation, little information is available concerning the effect of varying the level of sedation on patients' subsequent mental health. We designed a randomized controlled trial to investigate the efficacy of sedation with the goal of maintaining the patient cooperative and interactive compared to the administration of sedation with the goal of maintaining the patient sedated. The first goal will be achieved by a discontinuous injection of a sedative, while the second goal will be achieved by a continuous infusion of the same sedative. In both groups pain relief will be provided in the same fashion with equal endpoints on a pain scoring scale. Our primary aim is to investigate whether differences in the occurrence of post-traumatic stress disorders (PTSD), anxiety, and depression are related to the choice of sedation-analgesia strategies. Secondary endpoints include the length of ICU stay, as indicated by the time to discharge from the ICU, the time to separation from mechanical ventilation, the rates of pulmonary and extra-pulmonary complications, and hospital length of stay. These endpoints will be compared between the two groups.
Condition | Intervention | Phase |
---|---|---|
Critical Illness Respiratory Failure |
Drug: midazolam with 2 different levels of sedation scores |
Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Single Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Trial on The Efficacy of Sedation in Mechanically Ventilated Critically Ill Patients |
Estimated Enrollment: | 126 |
Study Start Date: | February 2003 |
Estimated Study Completion Date: | January 2007 |
Ages Eligible for Study: | 16 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Switzerland | |
Geneva University Hospitals | |
Geneva, Switzerland, 1211 |
Principal Investigator: | Miriam M Treggiari, MD | Geneva University Hospitals |
Study ID Numbers: | 3200-068312, 2002DR2266 |
Study First Received: | September 15, 2005 |
Last Updated: | January 9, 2007 |
ClinicalTrials.gov Identifier: | NCT00221520 History of Changes |
Health Authority: | Switzerland: Swissmedic |
Sedation, mechanical ventilation |
Respiratory Insufficiency Respiratory Tract Diseases Critical Illness Respiration Disorders Midazolam |
Disease Attributes Pathologic Processes Respiratory Insufficiency |
Respiratory Tract Diseases Critical Illness Respiration Disorders |